Sharon Bio-Medicine Ltd has informed BSE that a Meeting of the Board of Directors of the Company is scheduled to be held on November 10, 2015, inter alia, to consider adoption of Un-audited Financial Result for the Quarter ended on September 30, 2015.<BR><BR>In terms of Code of conduct adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be closed for the corporate invent as stated below:<BR><BR>- Window closure period - November 06, 2015 to November 16, 2015.<BR><BR>The trading window will open on November 17, 2015.
|